Downregulation and Upregulation of Glial Connexins May Cause Synaptic Imbalances Responsible for the Pathophysiology of Bipolar Disorder

CNS Neuroscience and Therapeutics

Volumn 17, Issue 5, 2011, Pages 281-293

  Mitterauer, Bernhard J ^a  

^a Psychopathology and Brain Philosophy   (Austria)

Author keywords

Astrocytic syncytium; Bipolar disorder; Cognitive impairment; Dysregulations; Imbalances; Tripartite synapses

Indexed keywords

CARBAMAZEPINE; CONNEXIN 43; GAP JUNCTION PROTEIN; LITHIUM; NEUROTRANSMITTER; PHOSPHOLIPASE A2; VALPROIC ACID;

ARTICLE; ASTROCYTE; BIPOLAR DISORDER; COGNITIVE DEFECT; DEPRESSION; DISEASE MODEL; DRUG MECHANISM; GENE MUTATION; GLIA CELL; HUMAN; MANIA; MEMORY DISORDER; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SYNAPSE; SYNAPTIC TRANSMISSION; SYNCYTIUM;

BIPOLAR DISORDER; CONNEXINS; DOWN-REGULATION; HUMANS; MODELS, NEUROLOGICAL; NEUROGLIA; SYNAPSES; UP-REGULATION;

EID: 80053180588     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00178.x     Document Type: Article

References (74)

1. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006;11:965-978.
2. Akiskal HS, McKinney WT. Depressive disorders: Towards a unified hypothesis. Science 1973;182:20-29.
3. Hertz L, Hansson E, Rönnbäck L. Signaling and gene expression in the neuron-glia unit during brain function and dysfunction: Holger Hydén in memoriam. Neurochem Int 2001;39:227-252.
4. Choudary PV, Molnar M, Evans SJ, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 2005;102:15653-15658.
5. Fields RD. The other brain. New York Simon and Schuster, 2010.
6. Bowley MP, Drevets WC, Ongür D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002;52:404-412.
7. Li L, Ma N, Li Z, et al. Prefrontal white matter abnormalities in young adult with major depressive disorder: A diffusion tensor imaging study. Brain Res 2007;1168:124-128.
8. Brauch R, El-Masri MA, Parker J, El-Mallakh R. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals. J Affect Disord 2009;91:87-90.
9. Bezchlibnyk YB, Sun X, Wang JF, McQueen GM, McEwen BS, Young LT. Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder. J Psychiatry Neurosci 2007;32:203-210.
10. Machado-Vieira R, Manji HK, Zarate CA. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist 2009;15:525-539.
11. Mitterauer B. Imbalance of glial-neuronal interaction in synapses: A possible mechanism of the pathophysiology of bipolar disorder. Neuroscientist 2004;10:199-206.
12. Smit AB, Syad NI, Schaap D, et al. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 2001;411:261-228.
13. Mitterauer B. The syncytiopathy hypothesis of depression: Downregulation of glial connexins may protract synaptic information processing and cause memory impairment. Med Hypotheses 2010;74:497-502.
14. Dermietzel R, Spray DC. From neuroglue to glia: A prologue. Glia 1998;24:1-7.
15. Giaume C, Theis M. Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system. Brain Res Rev 2009; doi: .
16. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: Glia, the unacknowledged partner. Trends in Neurosci 1999;22:205-215.
17. Ransom BR, Ye Z. Gap junctions and hemichannels. In: Kettenmann H, Ransom BR, editors. Neuroglia. Oxford Oxford University Press, 2005;177-189.
18. Gaietta G, Deerinck TJ, Adams SR, et al. Multicolour and electron microscopic imaging of connexin trafficking. Science 2002;296:503-507.
19. Robertson JM. The astrocentric hypothesis: Proposed role of astrocytes in consciousness and memory formation. J Physiol (Paris) 2002;96:251-255.
20. Mitterauer B. Where and how could intentional programs be generated in the brain? A hypothetical model based on glial-neuronal interactions. BioSystems 2007;88:101-112.
21. Dermietzel R. Diversification of gap junction proteins (connexins) in the central nervous system and the concept of functional compartments. Cell Biol Int 1998;22:719-730.
22. Dere E, De Souza-Silva MA, Frisch C, Teubner B, Söhl G, Willecke K, Huston JP. Connexin 30 deficient mice show increased emotionality and decreased activity in the open field along with neurochemical changes. Eur J Neurosci 2003;18:629-638.
23. Frisch C, Theis M, De Souza-Silva MA, et al. Mice with astrocyte-directed inactivation of connexin 43 exhibit increased exploratory behaviour, impaired motor capacities, and changes in brain acetylcholine levels. Eur Neurosci 2003;18:2313-2318.
24. Banaclocha MAM. Magnetic storage of information in the human cerebral cortex: A hypothesis for memory. Intern J Neurosci 2005;115:329-337.
25. Caudle RM. Memory in astrocytes: A hypothesis. Theor Biol Med Model 2006. Available from: [Accessed 18 January 2006.
26. Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006;86:1009-1031.
27. Newman EA. Glia and synaptic transmission. In: Kettenmann H, Ransom BR, editors. Neuroglia. Oxford Oxford University Press, 2005;355-366.
28. Parpura V, Haydon PG. Physiological astrocyte calcium levels stimulate glutamate release to modulate neurons. Proc Natl Acad Sci U S A 2000;97:8629-8634.
29. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006;440:1054-1059.
30. Sul JY, Orosz G, Givens RS, Haydon PG. Astrocytic connectivity in the hippocampus. Neuron Glia Biology 2004;1:3-11.
31. Mitterauer B. An interdisciplinary approach towards a theory of consciousness. BioSystems 1998;45:99-121.
32. Aulds DS, Robitaille R. Glial cells and neurotransmission: An inclusive view of synaptic function. Neuron 2003;40:389-400.
33. Kettenmann H, Steinhäuser C. Receptors for neurotransmitters and hormones. In: Kettenmann H, Ransom BR, editors. Neuroglia. Oxford Oxford University Press, 2005;131-145.
34. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC American Psychiatric Association, 1998.
35. Harvey PO, Le Bastard G, Pochon JB, Levy R, Allilaire JF, Dubois B, Fossati P. Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res 2004;38:567-576.
36. Benca R, Duncan MJ, Frank E, McClung C, Nelson RJ, Vincentic A. Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges. Brain Res Rev 2009;62:57-70.
37. Bibring E. The mechanism of depression. In: Greenacre P, editor. Affective disorders. New York International University Press, 1953;13-28.
38. Mitterauer B. Narziss und Echo. Ein psychobiologisches Modell der depression. Vienna Springer, 2009.
39. Post RM. Mood disorders: Somatic treatment. In: Kaplan JH, Sadock BJ, editors. Comprehensive textbook of psychiatry. Baltimore Williams and Wilkins, 1995;1152-1178.
40. Hydén H. The neuron. In: Brachet J, Mirsky AE, editors. The cell biochemistry, physiology, morphology 4. New York Academic Press, 1960;215-223.
41. Bunney WE, Davis JM. Norepinephrine in depressive reactions: A review. Arch Gen Psychiatry 1965;13:485-494.
42. Schildkraut JJ. The cholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 1965;122:509-522.
43. Siever LJ, Davis KL. Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 1985;142:1017-1031.
44. Berk M, Dodd S, Kauer-Sant'Anna M, Mahli S, Bourin M, Kapczinski F, Norman T. Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand 2007; 116(Suppl):41-49.
45. Burn DJ. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Mov Disord 2002;17:445-454.
46. Abrams CK, Rash JE. Connexins in the nervous system. In: Harris A, Locke D, editors. Connexins. New York Springer, 2009;323-357.
47. Dermietzel R, Gao Y, Scemes E, et al. Connexin 43 null mice reveal that astrocytes express multiple connexins. Brain Res Rev 2000;32:45-56.
48. Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton A. Connexin 43 enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer 2001;92:130-138.
49. Suadicani SO, De Pina-Benabou ME, Urban-Maldonado M, Spray DC, Scemes E. Acute downregulation of Cx43 alters P2Y receptor expression levels in mouse spinal cord astrocytes. Glia 2003;42:160-171.
50. Iacobas DA, Urban-Maldonado M, Iacobas S, Scemes E, Spray DC. Array analysis of gene expression in connexin-43 null astrocytes. Physiol Genomics 2003;15:177-190.
51. Rouach N, Calvo CF, Glowinski J, Giaume C. Brain macrophages inhibit gap junctional communication and downregulate connexin 43 expression in cultured astrocytes. Eur J Neurosci 2002;15:403-407.
52. Gonzalez MMC, Aston-Jones G. Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats. PNAS 2008;105:4898-4903.
53. Lucassen PJ, Heine VM, Müller MB, et al. Stress, depression and hippocampal apoptosis. CNS Neurol Disord-Drug Targets 2006;5:531-546.
54. McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J Affect Disord 2009;119:1-8.
55. Perea G, Araque A. Glia modulates synaptic transmission. Brain Res Rev 2009; doi:.
56. Mitterauer B. Pseudoomnipotence: A model of the manic syndrome. In: Kotlar MB, editor. New developments in mania research. New York Nova Science Publishers, 2006;161-178.
57. Mellerup E, Kristensen F. Mania as a dysfunction of reentry: Application of Edelman's and Tononi's hypothesis for consciousness to a psychiatric disorder. In: Kapur S, Lecrubier Y, editors. Dopamine in the pathophysiology and treatment of schizophrenia. London Martin Dunitz, 2004;177-205.
58. Edelman CM, Tononi C. A universe of consciousness. New York Basic Books, 2000.
59. Fleck DE, Shear PK, Zimmermann ME, et al. Verbal memory in mania: Effects of clinical state and task requirements. Bipolar Disord 2003;5:375-380.
60. Baddeley A. The fractionation of working memory. Proc Natl Acad Sci U S A 1996;93:13468-13472.
61. Chowdhury R, Ferrier IN, Thompson JM. Neural correlates of cognitive dysfunction. Curr Opin Psychiatry 2003;16:7-12.
62. Beyer EC, Berthoud VM. The family of connexin genes. In: Harris AL, Locke D, editors. Connexins. New York Springer, 2009;3-26.
63. Musil LS. Biogenesis and degradation of gap junctions. In: Harris AL, Locke D, editors. Connexins. New York Springer, 2009;225-240.
64. Wei Z, Nwagwu C, Duc ML, Wee YV, Hua S, Couldwell WT. Increased invasive capacity of connexin 43-overexpressing malignant glioma cells. J Neurosurgery 2003;99:1039-1046.
65. Hanstein R, Trotter J, Behl C, Clement AB. Increased connexin 43 expression as a potential mediator of the neuroprotective activity of the corticotropin-releasing hormone. Mol Endocrinology 2009;23:1479-1493.
66. 2 gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific. Psychopharmacology 2007;194:333-345.
67. Sun GY, Jensen MD, Yu S, Wood WG, Gonzalez FA, Simonyl AY, Weisman GA. Phospholipase A2 in astrocytes: Responses to oxidative stress, inflammation, and G protein-coupled receptor agonists. Mol Neurobiol 2005;31:27-41.
68. Houades V, Koulakoff A, Ezan P, Seif I, Giaume C. Gap junction-mediated astrocytic networks in the mouse barrel cortex. J Neurosci 2008;28:5207-5217.
69. Giaume C, Maravall M, Welker E, Bonvento The barrel cortex as a model to study dynamic neuroglial interaction. Neuroscientist 2009;15:351-366.
70. Nagy JI, Dudek FE, Rash JE. Update on connexins and gap junctions in neurons and glia in the mammalian nervous system. Brain Res Rev 2004;47:191-215.
71. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene, stressful life events and risk of depression: A meta-analysis. JAMA 2009;301:2462-2471.
72. Sebat J. Major changes in our DNA lead to major changes in our thinking. Nat Genet 2007;39(Suppl):53-55.
73. Fields RD. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008;31:361-370.
74. Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res 2009;112:54-64.